74 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 32441169 | The effect of chronic neuropeptide-S treatment on non-motor parameters in experimental model of Parkinson's disease. | 2021 Aug | 1 |
2 | 34512945 | Neuroprotective Effect of Intrastriatal Caffeic Acid Phenethyl Ester Treatment in 6-OH Dopamine Model of Parkinson's Disease in Rats. | 2021 | 1 |
3 | 27844282 | Morphological Changes in a Severe Model of Parkinson's Disease and Its Suitability to Test the Therapeutic Effects of Microencapsulated Neurotrophic Factors. | 2017 Dec | 1 |
4 | 27915043 | Involvement of BDNF/TrkB signaling in the effect of diphenyl diselenide on motor function in a Parkinson's disease rat model. | 2017 Jan 15 | 2 |
5 | 28247332 | Intranasal Administration of GDNF Protects Against Neural Apoptosis in a Rat Model of Parkinson's Disease Through PI3K/Akt/GSK3β Pathway. | 2017 May | 1 |
6 | 28504195 | FGF18 protects against 6-hydroxydopamine-induced nigrostriatal damage in a rat model of Parkinson's disease. | 2017 Jul 25 | 3 |
7 | 28611572 | 4R-Cembranoid Improves Outcomes after 6-Hydroxydopamine Challenge in Both In vitro and In vivo Models of Parkinson's Disease. | 2017 | 1 |
8 | 28004763 | Tyrosine Hydroxylase Binding to Phospholipid Membranes Prompts Its Amyloid Aggregation and Compromises Bilayer Integrity. | 2016 Dec 22 | 1 |
9 | 25999268 | Methodology and effects of repeated intranasal delivery of DNSP-11 in a rat model of Parkinson's disease. | 2015 Aug 15 | 2 |
10 | 24297323 | Ceftriaxone increases glutamate uptake and reduces striatal tyrosine hydroxylase loss in 6-OHDA Parkinson's model. | 2014 Jun | 4 |
11 | 24462728 | High frequency stimulation of subthalamic nucleus results in behavioral recovery by increasing striatal dopamine release in 6-hydroxydopamine lesioned rat. | 2014 Apr 15 | 1 |
12 | 25230286 | Intraventricular injection of 6-hydroxydopamine results in an increased number of tyrosine hydroxylase immune-positive cells in the rat cortex. | 2014 Nov 7 | 2 |
13 | 23018122 | Differential sensitivity of cranial and limb motor function to nigrostriatal dopamine depletion. | 2013 Jan 15 | 1 |
14 | 23279934 | Simvastatin induces neuroprotection in 6-OHDA-lesioned PC12 via the PI3K/AKT/caspase 3 pathway and anti-inflammatory responses. | 2013 Mar | 3 |
15 | 23539311 | Neurotoxic effects of berberine on long-term L-DOPA administration in 6-hydroxydopamine-lesioned rat model of Parkinson's disease. | 2013 Jun | 3 |
16 | 23652161 | Neuroprotective and behavioural assessments of an imidazolium compound (DBZIM) in a rat model of Parkinson's disease induced by 6-OHDA. | 2013 Sep 5 | 1 |
17 | 23714698 | Catechin attenuates behavioral neurotoxicity induced by 6-OHDA in rats. | 2013 Sep | 1 |
18 | 23868341 | Dynamic expressions of Beclin 1 and tyrosine hydroxylase in different areas of 6-hydroxydopamine-induced Parkinsonian rats. | 2013 Oct | 3 |
19 | 22048886 | Ether-à-go-go 1 (Eag1) potassium channel expression in dopaminergic neurons of basal ganglia is modulated by 6-hydroxydopamine lesion. | 2012 Apr | 1 |
20 | 22622825 | Curcumin protects nigral dopaminergic neurons by iron-chelation in the 6-hydroxydopamine rat model of Parkinson's disease. | 2012 Jun | 1 |
21 | 22842585 | Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats. | 2012 Sep 18 | 1 |
22 | 22850559 | A novel use of combined tyrosine hydroxylase and silver nucleolar staining to determine the effects of a unilateral intrastriatal 6-hydroxydopamine lesion in the substantia nigra: a stereological study. | 2012 Sep 30 | 1 |
23 | 20570658 | Efficacy of Tyrosine Hydroxylase gene modified neural stem cells derived from bone marrow on Parkinson's disease--a rat model study. | 2010 Jul 30 | 2 |
24 | 18816795 | 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum. | 2009 Feb 15 | 5 |
25 | 19844994 | The dual dopamine-glutamate phenotype of growing mesencephalic neurons regresses in mature rat brain. | 2009 Dec 20 | 1 |
26 | 18042492 | Glutamate in dopamine neurons: synaptic versus diffuse transmission. | 2008 Aug | 4 |
27 | 18420351 | Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease. | 2008 May 15 | 2 |
28 | 18430361 | Bilobalide inhibits 6-OHDA-induced activation of NF-kappaB and loss of dopaminergic neurons in rat substantia nigra. | 2008 May | 1 |
29 | 18706980 | Enhanced glutamatergic phenotype of mesencephalic dopamine neurons after neonatal 6-hydroxydopamine lesion. | 2008 Sep 22 | 2 |
30 | 17914186 | Reversible unilateral nigrostriatal pathway inhibition induced through expression of adenovirus-mediated clostridial light chain gene in the substantia nigra. | 2007 | 1 |
31 | 15717064 | Tyrosine hydroxylase replacement in experimental Parkinson's disease with transvascular gene therapy. | 2005 Jan | 3 |
32 | 16298737 | Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease. | 2005 Oct | 1 |
33 | 14689453 | Estrogen interacts with the IGF-1 system to protect nigrostriatal dopamine and maintain motoric behavior after 6-hydroxdopamine lesions. | 2004 Jan 1 | 3 |
34 | 14696016 | Lesion of subthalamic or motor thalamic nucleus in 6-hydroxydopamine-treated rats: effects on striatal glutamate and apomorphine-induced contralateral rotations. | 2004 Mar 15 | 4 |
35 | 15053859 | Normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism with intravenous nonviral gene therapy and a brain-specific promoter. | 2004 Apr | 1 |
36 | 15142343 | The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease. | 2004 May | 1 |
37 | 15246853 | Quantitative analyses of GFRalpha-1 and GFRalpha-2 mRNAs and tyrosine hydroxylase protein in the nigrostriatal system reveal bilateral compensatory changes following unilateral 6-OHDA lesions in the rat. | 2004 Aug 6 | 1 |
38 | 12691607 | Correction of a rat model of Parkinson's disease by coexpression of tyrosine hydroxylase and aromatic amino acid decarboxylase from a helper virus-free herpes simplex virus type 1 vector. | 2003 Mar 20 | 5 |
39 | 12965246 | Failure of estrogen to protect the substantia nigra pars compacta of female rats from lesion induced by 6-hydroxydopamine. | 2003 Oct 3 | 2 |
40 | 14673496 | Long term gene therapy of Parkinson's disease using immortalized rat glial cell line with tyrosine hydroxylase gene. | 2003 Dec | 4 |
41 | 11983283 | Induction of tyrosine hydroxylase expression in rat fetal striatal precursor cells following transplantation. | 2002 May 10 | 1 |
42 | 12165403 | Neuroprotective effect of the monoamine oxidase inhibitor PF 9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine] on rat nigral neurons after 6-hydroxydopamine-striatal lesion. | 2002 Aug 30 | 2 |
43 | 12176170 | Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease. | 2002 Aug 30 | 1 |
44 | 12658754 | Experimental study on heterograft of glomus cells of carotid body for hemiparkinsonian rats. | 2002 | 1 |
45 | 11241387 | Comparison of unilateral and bilateral intrastriatal 6-hydroxydopamine-induced axon terminal lesions: evidence for interhemispheric functional coupling of the two nigrostriatal pathways. | 2001 Apr 2 | 1 |
46 | 10694827 | Long-term phenotypic correction of rodent hemiparkinsonism by gene therapy using genetically modified myoblasts. | 2000 Mar | 1 |
47 | 10719076 | N-terminal tripeptide of IGF-1 (GPE) prevents the loss of TH positive neurons after 6-OHDA induced nigral lesion in rats. | 2000 Mar 24 | 1 |
48 | 10865059 | On the altered expression of tyrosine hydroxylase and calbindin-D 28kD immunoreactivities and viability of neurons in the ventral tegmental area of Tsai following injections of 6-hydroxydopamine in the medial forebrain bundle in the rat. | 2000 Jun 30 | 1 |
49 | 10945765 | Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-L-amino-acid decarboxylase, and GTP cyclohydrolase I for gene therapy of Parkinson's disease. | 2000 Jul 20 | 1 |
50 | 9973233 | Differential effects of chemical sympathectomy on expression and activity of tyrosine hydroxylase and levels of catecholamines and DOPA in peripheral tissues of rats. | 1999 Jan | 3 |